136 related articles for article (PubMed ID: 38377992)
21. Decrypting UFMylation: How Proteins Are Modified with UFM1.
Banerjee S; Kumar M; Wiener R
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066455
[TBL] [Abstract][Full Text] [Related]
22. Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.
Rubio MD; Wood K; Haroutunian V; Meador-Woodruff JH
Neuropsychopharmacology; 2013 Sep; 38(10):1910-20. PubMed ID: 23571678
[TBL] [Abstract][Full Text] [Related]
23. Structural study of UFL1-UFC1 interaction uncovers the role of UFL1 N-terminal helix in ufmylation.
Banerjee S; Varga JK; Kumar M; Zoltsman G; Rotem-Bamberger S; Cohen-Kfir E; Isupov MN; Rosenzweig R; Schueler-Furman O; Wiener R
EMBO Rep; 2023 Dec; 24(12):e56920. PubMed ID: 37988244
[TBL] [Abstract][Full Text] [Related]
24. The UFM1 system regulates ER-phagy through the ufmylation of CYB5R3.
Ishimura R; El-Gowily AH; Noshiro D; Komatsu-Hirota S; Ono Y; Shindo M; Hatta T; Abe M; Uemura T; Lee-Okada HC; Mohamed TM; Yokomizo T; Ueno T; Sakimura K; Natsume T; Sorimachi H; Inada T; Waguri S; Noda NN; Komatsu M
Nat Commun; 2022 Dec; 13(1):7857. PubMed ID: 36543799
[TBL] [Abstract][Full Text] [Related]
25. ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation.
Wu Y; Zhang C; Liu X; He Z; Shan B; Zeng Q; Zhao Q; Zhu H; Liao H; Cen X; Xu X; Zhang M; Hou T; Wang Z; Yan H; Yang S; Sun Y; Chen Y; Wu R; Xie T; Chen W; Najafov A; Ying S; Xia H
Nat Commun; 2021 Apr; 12(1):2346. PubMed ID: 33879767
[TBL] [Abstract][Full Text] [Related]
26. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
[No Abstract] [Full Text] [Related]
27. UFL1 alleviates ER stress and apoptosis stimulated by LPS via blocking the ferroptosis pathway in human granulosa-like cells.
Li J; Tang X; Tu X; Jin Z; Dong H; Yang Q; Yao T; Pan Z
Cell Stress Chaperones; 2022 Sep; 27(5):485-497. PubMed ID: 35729487
[TBL] [Abstract][Full Text] [Related]
28. Tryptophan potentiates CD8
Qin R; Zhao C; Wang CJ; Xu W; Zhao JY; Lin Y; Yuan YY; Lin PC; Li Y; Zhao S; Huang Y
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326168
[TBL] [Abstract][Full Text] [Related]
29. PARP1 UFMylation ensures the stability of stalled replication forks.
Gong Y; Wang Z; Zong W; Shi R; Sun W; Wang S; Peng B; Takeda S; Wang ZQ; Xu X
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2322520121. PubMed ID: 38657044
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-like modifier 1 ligating enzyme 1 relieves cisplatin-induced premature ovarian failure by reducing endoplasmic reticulum stress in granulosa cells.
Tang X; Dong H; Fang Z; Li J; Yang Q; Yao T; Pan Z
Reprod Biol Endocrinol; 2022 May; 20(1):84. PubMed ID: 35610622
[TBL] [Abstract][Full Text] [Related]
31. Signaling from the RNA sensor RIG-I is regulated by ufmylation.
Snider DL; Park M; Murphy KA; Beachboard DC; Horner SM
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2119531119. PubMed ID: 35394863
[TBL] [Abstract][Full Text] [Related]
32. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy.
Li C; Li W; Xiao J; Jiao S; Teng F; Xue S; Zhang C; Sheng C; Leng Q; Rudd CE; Wei B; Wang H
EMBO Mol Med; 2015 Jun; 7(6):754-69. PubMed ID: 25851535
[TBL] [Abstract][Full Text] [Related]
33. Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.
Sun Z; Mai H; Xue C; Fan Z; Li J; Chen H; Huo N; Kang X; Tang C; Fang L; Zhao H; Han Y; Sun C; Peng H; Du Y; Yang J; Du N; Xu X
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040417
[TBL] [Abstract][Full Text] [Related]
34. NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells.
Zhong B; Zheng J; Wen H; Liao X; Chen X; Rao Y; Yuan P
Genes Genomics; 2022 Sep; 44(9):1071-1079. PubMed ID: 35353342
[TBL] [Abstract][Full Text] [Related]
35. Optimized protocol to detect protein UFMylation in cells and in vitro via immunoblotting.
Zhou J; Liang Q; Dong M; Ma X; Jin Y; Guan D; Liu J; Wang M; Cong YS
STAR Protoc; 2022 Mar; 3(1):101074. PubMed ID: 35036955
[TBL] [Abstract][Full Text] [Related]
36. Emerging role of protein modification by UFM1 in cancer.
Chung CH; Yoo HM
Biochem Biophys Res Commun; 2022 Dec; 633():61-63. PubMed ID: 36344165
[TBL] [Abstract][Full Text] [Related]
37. Emerging role of UFMylation in secretory cells involved in the endocrine system by maintaining ER proteostasis.
Cheng Y; Niu Z; Cai Y; Zhang W
Front Endocrinol (Lausanne); 2022; 13():1085408. PubMed ID: 36743909
[TBL] [Abstract][Full Text] [Related]
38. The UFM1 E3 ligase recognizes and releases 60S ribosomes from ER translocons.
Makhlouf L; Peter JJ; Magnussen HM; Thakur R; Millrine D; Minshull TC; Harrison G; Varghese J; Lamoliatte F; Foglizzo M; Macartney T; Calabrese AN; Zeqiraj E; Kulathu Y
Nature; 2024 Mar; 627(8003):437-444. PubMed ID: 38383789
[TBL] [Abstract][Full Text] [Related]
39. PD-1 signaling negatively regulates the common cytokine receptor γ chain via MARCH5-mediated ubiquitination and degradation to suppress anti-tumor immunity.
Liu R; Zeng LW; Li HF; Shi JG; Zhong B; Shu HB; Li S
Cell Res; 2023 Dec; 33(12):923-939. PubMed ID: 37932447
[TBL] [Abstract][Full Text] [Related]
40. FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer.
Liu J; Wei L; Hu N; Wang D; Ni J; Zhang S; Liu H; Lv T; Yin J; Ye M; Song Y
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
